Stephen O’rAhilly

Stephen O’rAhilly

Top Cited Scholar 2026
Auto-generated profile, based on publicly available information

Stephen O’rAhilly

Medical Research Council Metabolic Diseases Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2010 in Nature Genetics
Verified
Journal Article
Open access
PDF file
ESElizabeth K Speliotes
Elizabeth K Speliotes
MAMagic
Magic
CWCristen J Willer
Cristen J Willer
SBSonja I Berndt
Sonja I Berndt
KMKeri L Monda
Keri L Monda
OCon behalf of Procardis Consortium
on behalf of Procardis Consortium
Ruth Loos and colleagues report results of a large genome-wide association study for body mass index. They identify 18 new loci associated with this trait, some of which map near key hypothalamic regulators of energy balance. Obesity is globally prevalent and highly heritable, but its underlying genetic factors remain largely elusive. To identify genetic loci for obesity susceptibility, we examined associations between body mass index and ∼2.8 million SNPs in up to 123,865 individuals with targeted follow up of 42 SNPs in up to 125,931 additional individuals. We confirmed 14 known obesity susceptibility loci and identified 18 new loci associated with body mass index (P < 5 × 10−8), one of which includes a copy number variant near GPRC5B. Some loci (at MC4R, POMC, SH2B1 and BDNF) map near key hypothalamic regulators of energy balance, and one of these loci is near GIPR, an incretin receptor. Furthermore, genes in other newly associated loci may provide new insights into human body weight regulation.

23 October 2003 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
SSStephanie B. Seminara
Stephanie B. Seminara
SMSophie Messager
Sophie Messager
ECEmmanouella E. Chatzidaki
Emmanouella E. Chatzidaki
RTRosemary R. Thresher
Rosemary R. Thresher
JAJames S. Jr. Acierno
James S. Jr. Acierno
WCWilliam H. Colledge
William H. Colledge
Puberty, a complex biologic process involving sexual development, accelerated linear growth, and adrenal maturation, is initiated when gonadotropin-releasing hormone begins to be secreted by the hypothalamus. We conducted studies in humans and mice to identify the genetic factors that determine the onset of puberty.

16 September 1999 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
IFI. Sadaf Farooqi
I. Sadaf Farooqi
SJSusan A. Jebb
Susan A. Jebb
GLGill Langmack
Gill Langmack
ELElizabeth Lawrence
Elizabeth Lawrence
CCChristopher H. Cheetham
Christopher H. Cheetham
SOStephen O'RAhilly
Stephen O'RAhilly
Severely obese (ob/ob) mice are deficient in the adipocyte-derived hormone leptin, which acts on the hypothalamus to control appetite and energy expenditure.1 The administration of leptin to these mice corrects their obesity by reducing their food intake and increasing their energy expenditure.2-4 These mice also have hyperinsulinemia, corticosterone excess, and infertility, which also are reversed by treatment with leptin.5 In humans, serum leptin concentrations, in general, correlate positively with indexes of obesity.6,7 We previously described two cousins with severe, early-onset obesity and undetectable serum leptin concentrations who were homozygous for a frame-shift mutation in the leptin gene.8 In this report, we describe the results of a trial of therapy with recombinant human leptin in the older of these children, a nine-year-old girl.

20 March 2003 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
IFI. Sadaf Farooqi
I. Sadaf Farooqi
JKJulia M. Keogh
Julia M. Keogh
GYGiles S.H. Yeo
Giles S.H. Yeo
ELEmma J. Lank
Emma J. Lank
TCTim Cheetham
Tim Cheetham
SOStephen O'Rahilly
Stephen O'Rahilly
Melanocortin 4 receptor (MC4R) deficiency is the commonest monogenic form of obesity. However, the clinical spectrum and mode of inheritance have not been defined, pathophysiological mechanisms leading to obesity are poorly understood, and there is little information regarding genotype–phenotype correlations.

30 November 2007 in Science
Verified
Journal Article
Closed access
PDF file
TGThomas Gerken
Thomas Gerken
Christophe GirardChristophe Girard
Christophe Girard
YTYi-Chun Loraine Tung
Yi-Chun Loraine Tung
CWCelia J. Webby
Celia J. Webby
VSVladimir Saudek
Vladimir Saudek
CSChristopher J. Schofield
Christopher J. Schofield
Variants in theFTO(fat mass and obesity associated) gene are associated with increased body mass index in humans. Here, we show by bioinformatics analysis that FTO shares sequence motifs with Fe(II)- and 2-oxoglutarate–dependent oxygenases. We find that recombinant murine Fto catalyzes the Fe(II)- and 2OG-dependent demethylation of 3-methylthymine in single-stranded DNA, with concomitant production of succinate, formaldehyde, and carbon dioxide. Consistent with a potential role in nucleic acid demethylation, Fto localizes to the nucleus in transfected cells. Studies of wild-type mice indicate thatFtomessenger RNA (mRNA) is most abundant in the brain, particularly in hypothalamic nuclei governing energy balance, and thatFtomRNA levels in the arcuate nucleus are regulated by feeding and fasting. Studies can now be directed toward determining the physiologically relevant FTO substrate and how nucleic acid methylation status is linked to increased fat mass.

1 December 1999 in Nature
Verified
Journal Article
Closed access
PDF file
IBI. Barroso
I. Barroso
MGM. Gurnell
M. Gurnell
VCV. E. F. Crowley
V. E. F. Crowley
MAM. Agostini
M. Agostini
JSJ. W. Schwabe
J. W. Schwabe
SOS. O'Rahilly
S. O'Rahilly